US regulators reject Akcea and Ionis rare disease drugThe US Food and Drug Administration (FDA) rejected Akcea and Ionis’ application for the use of Waylivra in Share XUS regulators reject Akcea and Ionis rare disease drughttps://pharmaphorum.com/news/us-regulators-reject-akcea-ionis-rare-disease-drug/
